The Emerging Role of Extracellular Vesicles in Endocrine Resistant Breast Cancer

SIMPLE SUMMARY: Two-thirds of breast cancer patients present an estrogen receptor–positive tumor at diagnosis, and the main treatment options for these patients are endocrine therapies such as aromatase inhibitors, selective modulators of estrogen receptor activity or selective estrogen receptor dow...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: La Camera, Giusi, Gelsomino, Luca, Caruso, Amanda, Panza, Salvatore, Barone, Ines, Bonofiglio, Daniela, Andò, Sebastiano, Giordano, Cinzia, Catalano, Stefania
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7962645/
https://ncbi.nlm.nih.gov/pubmed/33800302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13051160
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky